Summary
Machine-generated summaryAOK Hessen in Germany invites pharmaceutical companies to conclude non-exclusive discount agreements under Section 130a Paragraph 8 of SGB V for finished medicinal products with various active ingredients or active ingredient combinations, using an Open House model. Companies can join at any time under uniform conditions; no individual negotiations take place. Contracts start earliest on 01.10.2026 and end on 30.09.2028, with a maximum duration of 24 months. Interested companies request participation documents and the contract from am-vertragsteam@he.aok.de, and must return them fully completed, stamped and signed in original. Every qualifying company gets a contract. This is not a public procurement under Directive 2014/24/EU. If AOK Hessen later runs exclusive tender procedures, these contracts end accordingly.
Description
Can I bid?
- Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
- The notice is written in German.
- Certificates from another EU country? Check the equivalents on eCertis
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago
More from this buyer
Full buyer profile6 open tenders right now
- Medicines - Conclusion of non-exclusive discount agreements under Section 130a (8) SGB V (Open House model) 244 days left
- Medicines - Conclusion of non-exclusive discount agreements under Sec. 130a Para. 8 SGB V (Open House model) 397 days left
- Medicines - Conclusion of non-exclusive discount agreements under Sec. 130a para. 8 SGB V (Open House model) 458 days left
This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| Siemens Healthineers AG | 42 | €17.4M | Sep 2026 |
| Philips GmbH | 21 | €7.2M | Sep 2026 |
| GlaxoSmithKline GmbH & Co. KG | 15 | n/a | Sep 2026 |
| ASTRAZENECA GMBH | 12 | n/a | Jul 2026 |
| Brainlab Sales GmbH | 11 | €4.9M | Sep 2026 |
Based on 1041 awards with a linked company profile over the last 2 years.
Similar tenders
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €11,290,021
- Buyer track record on Aperlena
- 6 notices tracked · 0 awarded
Never miss a tender like this
71 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.
Set up my alert